Publications
Publications 5926 - 5950 de 33557
| Titre | DOI |
|---|---|
|
Clinical Effectiveness of Intravenous Exenatide Infusion in Perioperative Glycemic Control after Coronary Artery Bypass Graft Surgery A Phase II/III Randomized Trial G. Besch; A. Perrotti; F. Mauny; M. Puyraveau; M. Baltres; G. Flicoteaux; L.Salomon Du Mont; B. Barrucand; E. Samain; S. Chocron; S. Pili-Floury 2017 |
10.1097/ALN.0000000000001838 |
|
Clinical effectiveness of single dose of intravenous dexamethasone on the duration of ropivacaine axillary brachial plexus block: the randomized placebo-controlled ADEXA trial J.C. Clement; G. Besch; M. Puyraveau; T. Grelet; D. Ferreira; L. Vettoretti; S. Pili-Floury; E. Samain; F. Berthier 2019 |
10.1136/rapm-2018-100035 |
|
Clinical effectiveness of the systematic use of the GRACE scoring system (in addition to clinical assessment) for ischaemic outcomes and bleeding complications in the management of NSTEMI compared with clinical assessment alone: a prospective study C. Guenancia; K. Stamboul; O. Hachet; V. Yameogo; F. Garnier; A. Gudjoncik; Y. Cottin; L. Lorgis 2016 |
10.1007/s00380-015-0695-8 |
|
Clinical effectiveness of ultrasound-guided dual transversus abdominis plane block for postoperative analgesia in open abdominal aortic surgery patients The randomised, double-blind ETAP trial J. Chenet; E. Dupont; L.Salomon du Mont; T. Levy; V. Salignon; M. Puyraveau; S. Pili-Floury; E. Samain; G. Besch 2020 |
10.1097/EJA.0000000000001240 |
|
Clinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial R.P. Giugliano; T.R. Pedersen; J.G. Park; G.M. De Ferrari; Z.A. Gaciong; R. Ceska; K. Toth; I. Gouni-Berthold; J. Lopez-Miranda; F. Schiele; F. Mach; B.R. Ott; E. Kanevsky; A.Lira Pineda; R. Somaratne; S.M. Wasserman; A.C. Keech; P.S. Sever; M.S. Sabatine; F.O.U.R.I.E.R. Investigators 2017 |
10.1016/S0140-6736(17)32290-0 |
|
Clinical Efficacy and Safety of Long-Term Compression in Patients with Mixed Arterial and Venous Etiology Ulcers in the Leg S. Elhomsy; J. Chrusciel; S. Sanchez; P. Elhomsy; J. Guillaumat 2022 |
10.1055/s-0041-1735204 |
|
Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group C. Regny; S. Malak; G. Manson; C. Sarkozy; A. Clavert; C. Herbaux; A. Chauchet; E. Jourdan; L. Sanhes; P. Godmer; L. Pascal; K. Le Du; L. Sutton; L. Voillat; J. Dupuis; B. Anglaret; R. Gressin 2016 |
|
|
Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group C. Regny; S. Malak; G. Manson; C. Sarkozy; A. Clavert; C. Herbaux; A. Chauchet; E. Jourdan; L. Sanhes; P. Godmer; L. Pascal; K. Le Du; L. Sutton; L. Voillat; J. Dupuis; B. Anglaret; R. Gressin 2016 |
|
|
Clinical Efficacy of the Rivbd Combination for Refractory/Relapsed (R/R) Mantle Cell Lymphoma (MCL) Patients: A Retrospective Study of the French Lysa Group C. Regny; S. Malak; G. Manson; C. Sarkozy; A. Clavert; C. Herbaux; A. Chauchet; E. Jourdan; L. Sanhes; P. Godmer; L. Pascal; K. Le Du; L. Sutton; L. Voillat; J. Dupuis; B. Anglaret; R. Gressin 2016 |
|
|
CLINICAL EFFICACY OF TOCILIZUMAB IN POLYMYALGIA RHEUMATICA: AN OPEN-LABEL STUDY E. Toussirot; A. Martin; M. Soubrier; S. Redeker; A. Regent; L. CRI 2015 |
10.1136/annrheumdis-2015-eular.5377 |
|
Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study E. Toussirot; A. Martin; M. Soubrier; S. Redeker; A. Regent; L. Cri 2015 |
|
|
Clinical Efficacy of Tocilizumab in Polymyalgia Rheumatica: An OPEN-Label Study E. Toussirot; A. Martin; M. Soubrier; S. Redeker; A. Regent; L. Cri 2015 |
|
|
Clinical efficacy of tocilizumab in polymylagia rheumatica: an open label study E. Toussirot; A. Martin; M. Soubrier; S. Redeker; A. Regent 2016 |
|
|
Clinical efficacy of tocilizumab in polymylagia rheumatica: an open label study E. Toussirot; A. Martin; M. Soubrier; S. Redeker; A. Regent 2016 |
|
|
Clinical epidemiology and resistance mechanisms of carbapenem-resistant Acinetobacter baumannii, French Guiana, 2008-2014 A. Mahamat; X. Bertrand; B. Moreau; D. Hommel; P. Couppie; C. Simonnet; H. Kallel; M. Demar; F. Djossou; M. Nacher 2016 |
10.1016/j.ijantimicag.2016.03.006 |
|
Clinical epidemiology of human AE in Europe D.A. Vuitton; F. Demonmerot; J. Knapp; C. Richou; F. Grenouillet; A. Chauchet; L. Vuitton; S. Bresson-Hadni; L. Millon 2015 |
10.1016/j.vetpar.2015.07.036 |
|
Clinical evaluation of a dressing with poly absorbent fibres and a silver matrix for managing chronic wounds at risk of infection: a non comparative trial S. Dalac; L. Sigal; A. Addala; M. Chahim; C. Faivre-Carrere; Z. Lemdjadi; S. Bohbot 2016 |
10.12968/jowc.2016.25.9.531 |
|
Clinical evaluation of a new collagen-like protein with von willebrand factor binding activity: toward a New VWF: CBA E. De Maistre; F. Volot-Genre; C. Ternisien; P. Nguyen; G. Mourey; M.E. Briquel; B. Tardy; L. Dumont; M.A. Bertrand; F. Dutrillaux; N. Hezard; B. Frotscher; D. Vandroux; M. Trossaert 2016 |
|
|
Clinical evaluation of a new collagen-like protein with von willebrand factor binding activity: toward a New VWF: CBA E. De Maistre; F. Volot-Genre; C. Ternisien; P. Nguyen; G. Mourey; M.E. Briquel; B. Tardy; L. Dumont; M.A. Bertrand; F. Dutrillaux; N. Hezard; B. Frotscher; D. Vandroux; M. Trossaert 2016 |
|
|
Clinical Evaluation of a Software Medical Device for the Self-Assessment of Patients Living with Multiple Sclerosis: Results of the MSCopilot Study E. Maillart; P. Labauge; M. Cohen; A. Maarouf; S. Vukusic; C. Donze; P. Gallien; J. de Seze; B. Bourre; T. Moreau; S. Bieuvelet; M. Vallee; F. Bertillot; A.L. Argoud; S. Zinai; A. Tourbah 2019 |
|
|
Clinical evaluation of portable oxygen concentrators: impact of pulse oxygen delivery on exercise J. Maris; B. Melloni; C. Rabec; J. Delrieu; T. Bonnevie; F.E. Gravier; F. Herengt; Y.Al Chikahanie; D. Foret; A. Chambellan; J. Gonzalez-Bermerjo; A. Cuvelier; J.F. Muir; M. Patout 2020 |
10.1183/13993003.congress-2020.949 |
|
Clinical evaluation of the xDP output compression strategy for cochlear implants A. Bozorg-Grayeli; N. Guevara; J.P. Bebear; M. Ardoint; S. Saai; M. Hoen; D. Gnansia; P. Romanet; J.P. Lavieille 2016 |
10.1007/s00405-015-3796-1 |
|
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers I. Labidi-Galy; T.De la Mott Rouge; O. Derbel; A. Wolfer; E. Kalbacher; T. Olivier; J.D. Combes; K. Heimgartner-Hu; O. Tredan; H. Guevara; P.E. Heudel; T. Reverdy; F. Bazan; V. Heinzelmann-Schwarz; M. Fehr; V. de Castelbajac; P. Vaflard; L. Crivelli; V. Bonadona; V. Viassolo; A. Buisson; L. Golmard; M. Rodrigues; I. Ray-Coquard 2019 |
10.1016/j.ygyno.2019.09.008 |
|
Clinical factors associated with prolonged response and survival under olaparib as maintenance therapy in BRCA mutated ovarian cancers S.I. Labidi-Galy; deL.Motte Rouge; O. Derbel; A. Wolfer; E. Kalbacher; T. Olivier; J.D. Combes; K. Hu-Heimgartner; O. Tredan; H. Guevara; V. Heinzelmann-Schwarz; M. Fehr; V. de Castelbajac; P. Vaflard; L. Crivelli; V. Bonadona; V. Viassolo; F. Bazan; M. Rodrigues; I.L. Ray-Coquard 2019 |
|
|
Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study C. Vuillard; M.Pineton de Chambrun; N. de Prost; C. Guerin; M. Schmidt; A. Dargent; J.P. Quenot; S. Preau; G. Ledoux; M. Neuville; G. Voiriot; M. Fartoukh; R. Coudroy; G. Dumas; E. Maury; N. Terzi; Y. Tandjaoui-Lambiotte; F. Schneider; M. Grall; E. Guerot; R. Larcher; S. Ricome; R. Le Mao; G. Colin; C. Guitton; L. Zafrani; E. Morawiec; M. Dubert; O. Pajot; H. Mentec; G. Plantefeve; D. Contou 2018 |
10.1186/s13613-018-0433-3 |